CTNM Overview
Upcoming Projects (CTNM)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (CTNM)
-
A Third Look: Discussing the Rational of LPA1R antagonism to Treat Idiopathic Pulmonary Fibrosis (IPF) and the Potential of PIPE-791 from Contineum Therapeutics
Tickers: CTNM, RHHBY, Boehringer Ingelheim
Executed On: May 08, 2026 at 04:00 PM EDT -
A Second Look: Discussing the Potential of LPA1R antagonism to Treat Idiopathic Pulmonary Fibrosis (IPF) and the Potential of PIPE-791 from Contineum Therapeutics
Tickers: CTNM, RHHBY, Boehringer Ingelheim
Executed On: Apr 28, 2026 at 03:00 PM EDT -
Discussing the Potential of LPA1R antagonism to Treat Idiopathic Pulmonary Fibrosis (IPF) and the Potential of PIPE-791 from Contineum Therapeutics
Tickers: CTNM, RHHBY, Boehringer Ingelheim
Executed On: Apr 20, 2026 at 11:00 AM EDT
Upcoming & Overdue Catalysts (CTNM)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (CTNM)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
